Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 49 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Goulas, Antonis [Clear All Filters]
Animal studies on glucagon-like peptide-1 receptor agonists and related polyagonists in nonalcoholic fatty liver disease..
Hormones (Athens).
(2024). Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis..
J Clin Exp Hepatol. 14(3), 101353.
(2024).
(2024). Retinal Vascular Lesions in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis..
J Pers Med. 13(7),
(2023). The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver disease..
Expert Rev Clin Pharmacol. 1-10.
(2023). The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver disease.
Expert Review of Clinical Pharmacology. 1 - 10.
(2023). Tirzepatide for Diabetes and Obesity: A New Window to the Treatment of Non-alcoholic Steatohepatitis..
Curr Med Chem.
(2023). Tirzepatide for Diabetes and Obesity: A New Window to the Treatment of Non-alcoholic Steatohepatitis.
Current Medicinal Chemistry. 30,
(2023).
(2022).
Association between hepatic steatosis and fibrosis indices and dietary habits, physical activity, and quality of life..
Arab J Gastroenterol.
(2022). Circulating adiponectin in patients with nonalcoholic fatty liver disease-related liver fibrosis: A systematic review and a meta-analysis..
J Gastroenterol Hepatol.
(2022). Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications..
Diabetes Obes Metab. 24(9), 1702-1720.
(2022). Adult hypophosphatasia treated with reduced frequency of teriparatide dosing..
J Musculoskelet Neuronal Interact. 21(4), 584-589.
(2021). Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease..
Arch Med Res. 52(1), 25-37.
(2021). Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents..
J Crohns Colitis.
(2021). Nonalcoholic fatty liver disease: lifestyle and quality of life..
Hormones (Athens).
(2021). Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease..
Eur J Pharmacol. 907, 174272.
(2021). Comparative effectiveness of glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors on noninvasive indices of hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus..
Diabetes Metab Syndr. 14(6), 1913-1919.
(2020). Dissociating nonalcoholic steatohepatitis from hepatocellular carcinoma in obesity..
Hepatobiliary Surg Nutr. 9(1), 73-76.
(2020). The role of cannabidiol oil in schizophrenia treatment. a systematic review and meta-analysis..
Psychiatry Res. 291, 113246.
(2020). Selenium and selenoprotein P in nonalcoholic fatty liver disease..
Hormones (Athens). 19(1), 61-72.
(2020).
(2020). Effects of major adipokines and the -420 C > G resistin gene polymorphism on the long-term outcome of patients with acute ischemic stroke..
Int J Neurosci. 129(10), 978-985.
(2019). The ABCB1 2677G>T/A polymorphism is associated with baseline blood HDL-cholesterol levels in newly diagnosed hyperlipidemic patients..
Hellenic J Cardiol. 59(2), 122-126.
(2018). Fatal intoxication with antidepressants: a case with many culprits..
Forensic Sci Med Pathol. 14(2), 225-228.
(2018).